Trial Information
Human Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
Inclusion Criteria
Inclusion criteria:
- Adult women (age between 18 and 40) who stored the ovary before cancer therapy.
- Adult women who completed cancer therapy and are in remission.
- Adult women who desire to conceive and are ready to have a baby.
Exclusion criteria:
- Age under 18 or over 40 years old
- Women with a disease at high risk for ovarian metastasis (such as leukemia)
- Women with contraindication for surgery
- Women with contraindication for pregnancy
- Psychological instability to sustain pregnancy (diagnosed by a psychiatrist)
- Women who are HIV Positive
Type of Study:
Interventional
Study Design:
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Outcome Measure:
Comparision of orthotopic and heterotopic autotransplantation
Outcome Description:
The main purpose of this study is to investigate restoration of ovarian function and fertility by autotransplantation of human ovarian tissue using heterotopic and orthotopic techniques
Safety Issue:
No
Principal Investigator
Sam Kim, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
The University of Kansas Medical Center
Authority:
United States: Institutional Review Board
Study ID:
11214
NCT ID:
NCT01403675
Start Date:
May 2009
Completion Date:
May 2013
Related Keywords:
- Ovarian Autotransplantation Using Cryopreserved Ovarian Tissue in Women Treated for Cancer
- women with cancer whose ovarian tissue has been collected and stored in liquid nitrogen before cancer therapy (surgery, chemotherapy, radiotherapy),
- who are in remission (no recurrence of disease for 5 years),
- who are in normal organ function and have no contraindication for surgery or pregnancy, and
- who wish to restore ovarian function using stored ovarian tissue.
Name | Location |
The University of Kansas Medical Center |
Kansas City, Kansas 66160 |